Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthma

Matthew Chad Eastwood, John Busby, Johan Kolmert, Javier Zurita, Sven-Erik Dahlén, Pamela Jane McDowell, Judy Bradley, David Jackson, Ian Pavord, Ratko Djukanovic, Joseph Arron, Peter Bradding, Chris Brightling, Rekha Chaudhuri, Douglas Cowan, Stephen Fowler, Timothy Colin Hardman, Cecile Holweg, James Lordan, Adel Mansur, Douglas Robinson, Craig E. Wheelock, Liam Heaney, Unknown

Open source

DOI: 10.1183/23120541.01089-2024
Published: 2025-02-27
Container: ERJ Open Research
Publisher: European Respiratory Society (ERS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1183/23120541.01089-2024,
  title = {Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthma},
  author = {Matthew Chad Eastwood and John Busby and Johan Kolmert and Javier Zurita and Sven-Erik Dahlén and Pamela Jane McDowell and Judy Bradley and David Jackson and Ian Pavord and Ratko Djukanovic and Joseph Arron and Peter Bradding and Chris Brightling and Rekha Chaudhuri and Douglas Cowan and Stephen Fowler and Timothy Colin Hardman and Cecile Holweg and James Lordan and Adel Mansur and Douglas Robinson and Craig E. Wheelock and Liam Heaney and Unknown},
  year = {2025},
  journal = {ERJ Open Research},
  doi = {10.1183/23120541.01089-2024},
  url = {https://doi.org/10.1183/23120541.01089-2024}
}

RIS

TY  - JOUR
TI  - Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthma
AU  - Matthew Chad Eastwood
AU  - John Busby
AU  - Johan Kolmert
AU  - Javier Zurita
AU  - Sven-Erik Dahlén
AU  - Pamela Jane McDowell
AU  - Judy Bradley
AU  - David Jackson
AU  - Ian Pavord
AU  - Ratko Djukanovic
AU  - Joseph Arron
AU  - Peter Bradding
AU  - Chris Brightling
AU  - Rekha Chaudhuri
AU  - Douglas Cowan
AU  - Stephen Fowler
AU  - Timothy Colin Hardman
AU  - Cecile Holweg
AU  - James Lordan
AU  - Adel Mansur
AU  - Douglas Robinson
AU  - Craig E. Wheelock
AU  - Liam Heaney
AU  - Unknown
PY  - 2025
JO  - ERJ Open Research
DO  - 10.1183/23120541.01089-2024
UR  - https://doi.org/10.1183/23120541.01089-2024
ER  -

APA

Eastwood, M. C., Busby, J., Kolmert, J., Zurita, J., Dahlén, S., McDowell, P. J., Bradley, J., Jackson, D., Pavord, I., Djukanovic, R., Arron, J., Bradding, P., Brightling, C., Chaudhuri, R., Cowan, D., Fowler, S., Hardman, T. C., Holweg, C., Lordan, J., Mansur, A., Robinson, D., Wheelock, C. E., Heaney, L., & Unknown (2025). Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthma. ERJ Open Research. https://doi.org/10.1183/23120541.01089-2024

Source records

crossref · retrieved 2026-09-26T18:51:06.160Z